Related Experiment Videos
Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and
Stuart J Pocock1, Susan E Assmann, Laura E Enos
1Medical Statistics Unit, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK. stuart.pocock@lshtm.ac.uk
Statistics in Medicine
|September 27, 2002
Summary
This study reviews how clinical trial baseline data is used in medical journals. It highlights issues like overused subgroup analyses and inconsistent covariate adjustment, recommending predefined statistical plans.
Area of Science:
- Clinical Trials
- Medical Statistics
- Scientific Publishing
Background:
- Clinical trials collect extensive baseline patient data at randomization.
- Baseline data is crucial for subgroup analyses, covariate adjustment, and comparability assessments.
- Current practices in reporting the use of baseline data in journals vary significantly.
Purpose of the Study:
- To examine current practices in using baseline data in clinical trial reports.
- To identify statistical issues and inconsistencies in the reporting of baseline data analyses.
- To propose recommendations for improved future practices in handling baseline data.
Main Methods:
- A survey of 50 clinical trial reports from four major medical journals was conducted.
- The analysis focused on how baseline data was utilized for subgroup analyses, covariate adjustment, and baseline comparisons.
- Statistical ramifications and common problems in reporting were explored.
Main Results:
- Overuse and overinterpretation of subgroup analyses were observed.
- Inconsistent application of covariate-adjustment and lack of clear selection guidelines were identified.
- Misuse of significance tests for baseline comparability and overuse of baseline comparisons were noted.
Conclusions:
- There is a need for clearer guidelines on the statistical analysis and reporting of baseline data in clinical trials.
- Predefined statistical analysis plans are essential for the appropriate use of baseline data.
- Addressing these issues can improve the rigor and interpretation of clinical trial findings.